/Companies

Praesidia Biotherapeutics

Arlington, US · Founded 2021 · Delaware corporation · 5 employees on LinkedIn

Find your way into Praesidia Biotherapeutics

Sign up to find every way you can get introduced to Praesidia Biotherapeutics

  • Your email: who you already know at Praesidia Biotherapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Praesidia Biotherapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Founders & leadership

SC
Sohang ChatterjeeExecutive
PM
Pradip MajumderExecutive
JR
John RippleNamed on SEC filing

Board

STShawn Titcomb
Shawn TitcombMember Board Of DirectorsInvestor at Allele Capital Partners
MLMartin Lehr
Martin LehrIndependent Board DirectorFounder at Context Therapeutics

Reported raises · per SEC filings

Form D private placements

$11.4M disclosed across 2 rounds · 2021–2024

▶$7.4MraisedJul 2024 · 52 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sohang ChatterjeeExecutive Officer, Director
  • Shawn TitcombDirector
  • Pradip MajumderExecutive Officer
  • Martin LehrDirector
Offering amount
$15M
Amount sold
$7.4M
Sales commissions
$310K
Placement agents
Wilmington Capital Securities, LLC
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedAug 2022 · 55 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin LehrDirector
  • John RippleDirector
  • Sohang ChatterjeeExecutive Officer, Director
  • Shawn TitcombDirector
  • Pradip MajumderExecutive Officer
Offering amount
$10M
Amount sold
$4M
Sales commissions
$700K
Placement agents
Wilmington Capital Securities, LLC
First sale
Jul 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Praesidia Biotherapeutics raised?
Praesidia Biotherapeutics has disclosed $11.4M raised across 2 rounds.
Where is Praesidia Biotherapeutics headquartered?
Praesidia Biotherapeutics is headquartered in Arlington, US.